Acarix
0.275
SEK
-2.48 %
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
2 following
-2.48%
-12.7%
-9.54%
-18.4%
+44.89%
+44.74%
-56.88%
-69.09%
-96.28%
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Read moreMarket cap
292.53M SEK
Turnover
427.19K SEK
Revenue
6.24M
EBIT %
-1,242.79 %
P/E
-
Dividend yield-%
-
Financial calendar
13.2
2025
Annual report '24
ShowingAll content types
Redeye: Acarix Q3 2024 - Setting the stage for an exciting 2025
Acarix Publishes Third Quarter 2024 Report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools